SASAC issues new SOE investment guidelines for AI and biotechnology
Published · Updated
What happened
SASAC released new guidelines on October 27, 2026 for state-owned enterprises to give priority to investment in strategic emerging industries such as artificial intelligence and biotechnology.
Why it matters
The guidance can redirect large pools of state capital toward selected technologies, affecting financing conditions, competition, and acquisition activity across multiple sectors. It also provides a policy signal that may influence local regulators, banks, and listed SOE subsidiaries in near-term capital planning.
On October 27, 2026, the State-owned Assets Supervision and Administration Commission issued guidelines directing state-owned enterprises to prioritize investment in strategic emerging industries, including artificial intelligence and biotechnology. The move gives central policy backing to shift SOE capital allocation toward designated high-tech sectors rather than traditional assets. The near-term question is how quickly major SOEs, local SASAC systems, and listed subsidiaries translate the guidance into budgets, deals, and portfolio changes.
Watch for
SASAC publication of implementation FAQs or a task notice for central SOEs by 2026-10-31 Shanghai Stock Exchange and Shenzhen Stock Exchange filings from major SOEs on AI or biotech investment plans by 2026-10-31 China Securities Regulatory Commission statements or filing approvals tied to SOE restructuring into strategic emerging industries by 2026-10-31 Provincial SASAC notices aligning local SOE investment targets with the new central guidance by 2026-10-31